Klomp Margo, Damman Peter, Beijk Marcel A M, Tan Kim H, Balian Vruyr, de Luca Giuseppe, Tijssen Jan G P, Silber S, de Winter Robbert J
Department of Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands.
Coron Artery Dis. 2012 Jun;23(4):271-7. doi: 10.1097/MCA.0b013e328351aaed.
Percutaneous coronary interventions (PCIs) are increasingly being performed worldwide to treat patients with coronary artery disease. However, studies on the influence of ethnicity on clinical outcomes after PCI are scarce. In our current analysis, we evaluate the differences in baseline clinical, angiographic and procedural characteristics, and 12-month clinical outcomes in patients undergoing nonurgent PCI in Western Europe and in Asia.
We analyzed all patients enrolled in the worldwide e-HEALING (electronic Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) registry living in Western Europe and Asia. All patients were treated with at least one endothelial progenitor cell capturing stent. The main study outcome was target vessel failure at the 12-month follow-up, defined as the composite of cardiac death or myocardial infarction and target vessel revascularization.
A total of 3504 patients, 2873 living in Western Europe and 731 living in Asia, were assessed in the current analysis. Almost all of the baseline clinical and angiographic characteristics differed significantly between both populations. Target vessel failure at the 12-month follow-up occurred in 11.4% of the Western Europe patients and in 5.6% of the Asian patients (P<0.01).
We conclude that differences exist in the baseline, angiographic, and procedural characteristics between Western European and Asian patients undergoing nonurgent PCI. In addition, the 1-year clinical outcomes differ significantly after PCI between Western European and Asian patients. Our results indicate that reports from studies performed worldwide should include both overall and regional subgroup outcomes.
在全球范围内,经皮冠状动脉介入治疗(PCI)越来越多地用于治疗冠状动脉疾病患者。然而,关于种族对PCI术后临床结局影响的研究较少。在我们当前的分析中,我们评估了西欧和亚洲接受非紧急PCI患者的基线临床、血管造影和手术特征以及12个月临床结局的差异。
我们分析了全球e-HEALING(电子健康内皮加速内膜抑制新生内膜生长)注册研究中居住在西欧和亚洲的所有患者。所有患者均接受了至少一枚内皮祖细胞捕获支架治疗。主要研究结局是12个月随访时的靶血管失败,定义为心源性死亡或心肌梗死与靶血管血运重建的复合终点。
在当前分析中,共评估了3504例患者,其中2873例居住在西欧,731例居住在亚洲。几乎所有基线临床和血管造影特征在两组人群中均有显著差异。12个月随访时,西欧患者的靶血管失败发生率为11.4%,亚洲患者为5.6%(P<0.01)。
我们得出结论,西欧和亚洲接受非紧急PCI的患者在基线、血管造影和手术特征方面存在差异。此外,西欧和亚洲患者PCI术后1年的临床结局也有显著差异。我们的结果表明,全球范围内开展的研究报告应包括总体和区域亚组结局。